Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Farhana, Lulu ^a,b,c   Dawson, Marcia I ^d   Murshed, Farhan ^b   Das, Jayanta K ^a,b   Rishi, Arun K ^a,b,c   Fontana, Joseph A ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 3 CHLOROCINNAMIC ACID; ADAMANTANE DERIVATIVE; CD24 ANTIGEN; CYCLIN DEPENDENT KINASE 6; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; MICRORNA; MICRORNA 129; MICRORNA 134; MICRORNA 150; MICRORNA 202; MICRORNA 345; MICRORNA 382; MICRORNA 410; MICRORNA 578; MICRORNA 630; PHOSPHOPROTEIN PHOSPHATASE CDC14; PHOSPHOPROTEIN PHOSPHATASE CDC14A; PROTEIN BCL 2; PROTEIN C MYB; SMAD1 PROTEIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ABCC1 GENE; APOPTOSIS; ARTICLE; C MYB GENE; CANCER CELL; CANCER INHIBITION; CDC14A GENE; CDK6 GENE; CONTROLLED STUDY; CPEB3 GENE; DOWN REGULATION; EGFR GENE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IGF1R GENE; MOLECULAR DYNAMICS; PANCREAS CANCER; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REDUCTION; RNA DEGRADATION; RNA TRANSLATION; SMAD1 GENE; UPREGULATION;

ADAMANTANE; ANTIGENS, CD24; ANTIGENS, CD44; APOPTOSIS; CELL LINE, TUMOR; CINNAMATES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, BCL-2; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYB; RECEPTOR, IGF TYPE 1; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84877617341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061015     Document Type: Article

References (39)

1. Lee YS, Dutta A, (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
2. Nanna-Sinkam SP, Croce CM, (2011) Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol 5: 483-491.
3. Bhayani MK, Calin GA, Lai SY, (2012) Functional relevance of miRNA sequences in human disease. Mutat Res 731: 14-19.
4. Mott JL, (2009) Micro RNAs involved in tumor suppressor and oncogene pathways: Implication for hepatobiliary neoplasia. Hepatology 50: 630-637.
5. Bartel DP, (2009) MicroRNAs. Target recognition and regulatory functions. Cell 136: 215-233.
6. Park JY, Helm J, Coppola D, Kim D, Malafa M, et al. (2011) Micro RNAs in pancreatic ductal adenocarcinoma. World J Gastroenterol 17: 817-827.
7. Dawson MI, Fontana JA, (2010) The peptidomimetic 1-adamantyl-substituted and flex-het classes of retinoid-derived molecules: structures-activity relationships and retinoid receptor-independent anticancer activities. Mini Rev Med Chem 10: 455-491.
8. Farhana L, Dawson MI, Das JK, Murshed F, Xia Z, et al. (2012) Adamantyl retinoid-related molecules induce apoptosis in pancreatic cancer cells by inhibiting IGF-IR and Wnt/β-catenin pathways. J Oncol 2012: 796729.
9. Zhang Y, Dawson MI, Mohammad R, Rishi AK, Farhana L, et al. (2002) Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog. Blood 100: 2911-2918.
10. Farhana L, Dawson MI, Leid M, Wang L, Moore DD, et al. (2007) Adamantyl -substituted retinoid related molecules bind SHP and modulate the Sin3A repressor. Cancer Res 67: 318-325.
11. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
12. Beverly LJ, (2012) Regulation of antiapototic Bcl2-proteins by non-canonical interactions: the next step forward or two step back? J Cell Biochem 113: 3-12.
13. Lang G, White JR, Argent-Katwala MJ, Allinson CG, Weston K, (2005) Myb proteins regulate the expression of diverse target genes. Oncogene 24: 1375-1384.
14. Zhang J, Luo N, Luo Y, Peng Z, Zhang T, et al. (2012) microRNA-150 inhibits CD133-positive liver cancer cells through negative regulation of the transcription factor c-Myb. Int J Oncol 40: 747-756.
15. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. (2010) miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70: 1793-1703.
16. Ambros V, (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress and timing. Cell 113: 673-676.
17. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2006) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
18. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, et al. (2011) Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 717: 77-84.
19. Iorio MV, Visone R, DiLeva G, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 18: 8699-8707.
20. Saito Y, Liang G, Egger G, Friedman JM, Chaung JC, et al. (2006) Specific activation of micro RNA-127 with down regulation of proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
21. Bauer TW, Somcio RJ, Fan F, Liu W, Johnson M, et al. (2006) Regulatory role of c-Met in insulin-like growth factor-1receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol Cancer Ther 5: 1676-1682.
22. Moser C, Schachtschneider P, Lang SA, Gaumann A, Mori A, et al. (2008) Inhibition of insulin-like-growth factor-1-receptor (IGF-1R) using NVP-AWW541, a small molecule kinase inhibitor reduces orthotopic pancreatic cancer growth and angiogenesis. Eur J Cancer 44: 1577-1586.
23. Jia CY, Li HH, Zhu XC, Dong YW, Fu D, et al. (2011) Mir-223 suppresses cell proliferation by targeting IGF-1R. PloS One 6: 1-13.
24. Andrews GA, Xi S, Pomerantz RG, Gooding WE, Wentzel AL, et al. (2004) Mutation of p53 in head and neck squamous cell carcinoma correlates with BCL-2 expression and increased susceptibility to cisplatin-induced apoptosis. Head and Neck 26: 870-877.
25. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, et al. (2011) MicroRNA 150 directly targets MUC4 and suppressed growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 32: 1832-1839.
26. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, et al. (2008) miRNA analysis in B-cell chronic lymphocytic leukemia: proliferation centres characterized by low miR-150 and high BIC/miR 155 expression. J Pathol 215: 13-20.
27. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, et al. (2011) The role of microRNA-150 as a tumor suppression in malignant lymphoma. Leukemia 25: 1324-1334.
28. Lin M, Chen W, Huang J, Gao H, Ye Y, et al. (2011) MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep 25: 739-777.
29. Wu Q, Jin H, Yang Z, Luo G, Lu Y, et al. (2010) MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345.
30. Aggarwal S, Gupta S, Gupta MK, Murthy RS, Vyas SP, (2011) Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer. Crit Rev Ther Drug Carrier Syst 2 28: 293-356.
31. Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, et al. (2011) High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-bases adjuvant chemotherapy. Int J Oncol 38: 629-641.
32. Liu L, Shao X, Gao W, Zhang Z, Liu P, et al. (2012) MicroRNA-133b inhibits growth of non-small cell lung cancer by targeting the epidermal growth factor receptor. FEBS J 279: 3800-3812.
33. Haldar S, Basu A, (2011) Modulation of microRNAs by chemical carcinogens and anticancer drugs in human cancer; potential linking to therapeutic advantage. Mol Cell Pharmacol 3: 135-141.
34. Tsang WP, Kwok TT, (2010) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21: 140-146.
35. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, et al. (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-473.
36. Li Y, VandenBoom TG 2nd, Kong D, Wang Z, Ali S, et al. (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the recersal of epithelial-to-mesenchymal transistion in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69: 6704-6712.
37. McDermott AM, Heneghan HM, Miller N, Kerin MJ, (2011) The therapeutic potential of microRNAs: Disease modulators and drug targets,. Pharm Res 28: 3016-3029.
38. Bhardwaj A, Singh S, Singh AP, (2010) MicroRNA-based cancer therapeutics: Big hope from small RNAs. Mol Cell Pharmacol 2: 213-219.
39. Kota SK, Balasubramanian S, (2010) Cancer therapy via modulation of microRNA levels: a promising future. Drug Discov Today 15: 733-740.